FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.0  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


15270 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Over the counter nicotine replacement therapy Nicotine replacement therapy
överdos av natriumvalproat Valproate overdose
överdos av natriumvalproat, med oklar avsikt Valproate overdose
tröstätande förenat med andra psykiska störningar Psychogenic overeating
Overexposure to radioactive isotope NOS Overexposure to radioactive isotopes
hypergranulerande operationssår under sekundär sårläkning Over-granulating secondary intention surgical wound (finding)
övergripande malign tumör på oklart ställe Malignant neoplastic disease (disorder)
mer än 11 timmars nattfasta Overnight fasting period more than 11 hours
överridande höger ventrikuloarteriell klaff Pulmonary valve overriding ventricular septum (disorder)
Ovis musimon Ovis aries
ovotestis Ovotesticular disorder of sex development
Ovula Nabothi Retention cyst
oxacillinnatrium 250 mg/5 ml, pulver till oral lösning Product containing precisely oxacillin 50 milligram/1 milliliter conventional release oral suspension (clinical drug)
poäng enligt Oxford knee score, version 1.0 Oxford Knee Score using revised scoring system (observable entity)
Oxidase Oxidase
Oxo-acid-lyase Oxo-acid-lyase
Oxybuprocaine 0.4% eye drops Oxybuprocaine only product
oxibuprokainhydroklorid 0,4 %, ögondroppar Oxybuprocaine only product
oxibuprokainhydroklorid 0,4 %, ögondroppar för engångsbruk Oxybuprocaine only product
oxibutynin 3,9 mg/dag, transdermalt system Product containing precisely oxybutynin 162 microgram/1 hour prolonged-release transdermal patch (clinical drug)
oxibutyninhydroklorid 15 mg, tablett med modifierad frisättning Oxybutynin only product in oral dose form
oxibutyninhydroklorid 15 mg, depåtablett Oxybutynin only product in oral dose form
oxikodonhydroklorid 160 mg, tablett med modifierad frisättning Product containing only oxycodone in oral dose form (medicinal product form)
oxikodonhydroklorid 160 mg, depåtablett Product containing only oxycodone in oral dose form (medicinal product form)
Oxygenase Oxygenase
oximetazolinhydroklorid 0,025 %, näsdroppar Oxymetazoline hydrochloride 250 microgram/mL nasal solution
oximetazolinhydroklorid 0,05 %, ögondroppar Oxymetazoline hydrochloride 500 microgram/mL eye solution
oximetazolinhydroklorid 0,05 %, näsdroppar Oxymetazoline hydrochloride 500 microgram/mL nasal solution
oximorfon 10 mg, tablett med modifierad frisättning Oxymorphone only product in oral dose form
oximorfon 10 mg, depåtablett Oxymorphone only product in oral dose form
oximorfon 20 mg, tablett med modifierad frisättning Oxymorphone only product in oral dose form
oximorfon 20 mg, depåtablett Oxymorphone only product in oral dose form
oximorfon 40 mg, tablett med modifierad frisättning Oxymorphone only product in oral dose form
oximorfon 40 mg, depåtablett Oxymorphone only product in oral dose form
oximorfon 5 mg, tablett med modifierad frisättning Oxymorphone only product in oral dose form
oximorfon 5 mg, depåtablett Oxymorphone only product in oral dose form
Oxytocic preparation Medicinal product acting as oxytocic (product)
oxytocin 10 enheter/ml, infusionsvätska, lösning, flaska 1 ml Product containing precisely oxytocin 10 unit/1 milliliter conventional release solution for injection (clinical drug)
ostron, livsmedel Oyster (substance)
PegIntron, Redipen Product containing peginterferon alfa-2b (medicinal product)
PegIntron 120 mikrogram pulver + sterilt vatten 0,5 ml, Redipen Interferon alfa-2b (as peginterferon alfa-2b) 120 microgram powder for solution for injection pen
PegIntron 150 mikrogram pulver + sterilt vatten 0,5 ml, Redipen Interferon alfa-2b (as peginterferon alfa-2b) 150 microgram powder for solution for injection pen
PegIntron 50 mikrogram pulver + sterilt vatten 0,5 ml, Redipen Interferon alfa-2b (as peginterferon alfa-2b) 50 microgram powder for solution for injection pen
PegIntron 80 mikrogram pulver + sterilt vatten 0,5 ml, Redipen Interferon alfa-2b (as peginterferon alfa-2b) 80 microgram powder for solution for injection pen
PIE syndrome Löffler's syndrome (disorder)
Packing - action Insertion - action (qualifier value)
läkemedelseluerande stent innehållande paclitaxel 1 mikrogram/mm Paclitaxel 1 microgram/mm2 drug eluting stent (product)
Painful ejaculation Painful ejaculation
lambå från hårda gommen Flap (substance)
Palatoplasty Uvulopalatopharyngoplasty
Pale faeces Pale feces
Pale faeces Pale feces
ljus avföring, symtom Pale feces
blekröd färg Pale red colour
pamidronatdinatrium 3 mg/ml, infusionskoncentrat, flaska 5 ml Product containing precisely disodium pamidronate 3 milligram/1 milliliter conventional release solution for injection (clinical drug)
Pancreas excision Pancreatectomy
pankrelipas, amylas:lipas, kapsel à 183,49 g Amylase and pancrelipase and triacylglycerol lipase only product
pankrelipas, amylas:lipas, kapsel à 184,84 mg Amylase and pancrelipase and triacylglycerol lipase only product
pankrelipas, amylas:lipas, kapsel à 210,33 mg Amylase and pancrelipase and triacylglycerol lipase only product
pankrelipas, amylas:lipas, 278,72 %, kapsel Amylase and pancrelipase and triacylglycerol lipase only product
pankrelipas, amylas:lipas, kapsel à 312,17 mg Amylase and pancrelipase and triacylglycerol lipase only product
pankrelipas, amylas:lipas, kapsel à 346,86 mg Amylase and pancrelipase and triacylglycerol lipase only product
pankrelipas, amylas:lipas, 4 500 enheter, kapsel Amylase and pancrelipase and triacylglycerol lipase only product
pankrelipas, amylas:lipas, 62,81 % Amylase and pancrelipase and triacylglycerol lipase only product
pankrelipas, amylas:lipas, 62,81 %, kapsel Amylase and pancrelipase and triacylglycerol lipase only product
pankrelipas, amylas:lipas, kapsel à 94,3 mg Amylase and pancrelipase and triacylglycerol lipase only product
Pantoprazole sodium 40mg injection Pantoprazole (as pantoprazole sodium) 40 mg powder for solution for injection vial
Pantoprazole sodium 40mg m/r tablet Pantoprazole (as pantoprazole sodium) 40 mg gastro-resistant oral tablet
Pantoprazole sodium 40mg powder Pantoprazole (as pantoprazole sodium) 40 mg powder for solution for injection vial
Pantoprazole sodium 40mg/vial powder for injection Pantoprazole (as pantoprazole sodium) 40 mg powder for solution for injection vial
papainspecifikt extrakt Product containing papain (medicinal product)
papaya, livsmedel Papaya (substance)
Paphosia adorabilis Lophornis adorabilis (organism)
Papillary cystadenoma, borderline malignancy Papillary cystadenoma, borderline malignancy
Papillary mucinous cystadenoma, borderline malignancy Papillary mucinous cystadenoma, borderline malignancy
papillärt seröst cystadenokarcinom Serous cystadenocarcinoma
Papillary serous cystadenoma, borderline malignancy Serous papillary cystic tumour of borderline malignancy
papillom (förutom papillom i blåsa M-81201) Benign papilloma (morphologic abnormality)
antiinflammatoriskt medel med para-aminofenolderivat Para-aminophenol derivative
paracetamol 500 mg + klorfenaminmaleat 8 mg + fenylefrinhydroklorid 40 mg Product containing only chlorphenamine and paracetamol and phenylephrine (medicinal product)
paracetamol 500 mg + orfenadrincitrat 50 mg Orphenadrine and paracetamol only product
Paracetamol - chemical Product containing paracetamol (medicinal product)
Paracetamol 1g/sachet powder Paracetamol only product
Paracetamol 1g/sachet powder Paracetamol only product
paracetamol 500 mg, löslig tablett Product containing precisely paracetamol 500 milligram/1 each conventional release effervescent oral tablet (clinical drug)
paracetamol 650 mg + pentazocinhydroklorid 25 mg, kapseltablett Paracetamol 650 mg and pentazocine 25 mg oral tablet
paracetamol 650 mg + pentazocinhydroklorid 25 mg, tablett Paracetamol 650 mg and pentazocine 25 mg oral tablet
Paracetamol level abnormal Acetaminophen above therapeutic range
Paracetamol level normal Acetaminophen within therapeutic range
paracetamol 500 mg + koffein 65 mg, löslig tablett Product containing precisely caffeine 650 microgram/1 milliliter and paracetamol 5 milligram/1 milliliter conventional release oral solution (clinical drug)
Parafunctional occlusal trauma Secondary occlusal trauma
Parahyaena brunnea Hyaena brunnea (organism)
Paramyxovirus Genus Respirovirus (organism)
Paramyxovirus group Genus Respirovirus (organism)
syndrom med paraplegi, brakydaktyli och konformad epifys Autosomal recessive spastic ataxia of Charlevoix-Saguenay (disorder)
fasciokutan paraskapulär lambå Fasciocutaneous flap
fasciokutan paraskapulär lambå samt scapula Osteofasciocutaneous flap (substance)
parasomni orsakad av substans Parasomnia
Parathormone Parathyroid hormone
parecoxib 40 mg, pulver för beredning av injektionsvätska Parecoxib only product
parecoxib 40 mg, pulver för beredning av injektionsvätska + spädningsvätska Parecoxib only product

Start Previous Page 88 of 153 Next End


Reference Sets

Reference set descriptor

GB English

US English

Back to Start